Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations
2017 · Genetics in Medicine · 237 citations
https://doi.org/10.1038/gim.2017.101
M
Melissa Wasserstein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
221
Papers
7.4K
Citations
51
h-index
95
i10-index
Melissa Wasserstein is an academic researcher from Albert Einstein College of Medicine. The author has contributed to research in topics: Lysosomal Storage Disorders Research & Genomics and Rare Diseases & Metabolism and Genetic Disorders. The author has an h-index of 51, co-authored 188 publications.
ORCID: 0000-0003-2031-7817Papers by this author
worksConsensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency
2017 · Genetics in Medicine · 110 citations
https://doi.org/10.1038/gim.2017.7
A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year results
2022 · Genetics in Medicine · 91 citations
https://doi.org/10.1016/j.gim.2022.03.021
Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq project
2017 · European Journal of Human Genetics · 64 citations
https://doi.org/10.1038/ejhg.2016.178
Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation
2021 · Orphanet Journal of Rare Diseases · 62 citations
https://doi.org/10.1186/s13023-021-01842-0
The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children
2021 · Trials · 34 citations
https://doi.org/10.1186/s13063-020-04953-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat